AURA 2023 includes data and analyses from 2020–2022 (primarily 2020–2021) from various sources and reports on patterns and trends in antimicrobial use and appropriateness and antimicrobial resistance (AMR) in Australian acute and community healthcare settings.

This complete version of the Opioid Analgesic Stewardship in Acute Pain Clinical Care Standard describes what each quality statement means for patients and their families, clinicians, and health service organisations, and provides indicators for local monitoring. It includes information about using clinical care standards, and the background and evidence sources for this standard.

The Commission is seeking an Ongoing EL1 Senior Project Officer, Intergovernment Relations. 

Information on this vacancy and how to apply can be found in the link below. Applications for this role will close 11.59pm Australian Eastern Daylight Time (AEDT) Monday 8 December 2025.

Questions about the role can be directed to Vannary Sar on 02 7232 5550.

Advice was provided to the Commission by the Australian Government Solicitors supplementary to the 2021 Privacy Impact Assessment. Its findings and recommendations are presented in this report.

The purpose of the Electronic Medication Management Self-Assessment Tool User Guide (the Guide) is to support users of the Commission’s Electronic Medication Management Self-Assessment Tool (EMMSAT).

This fact sheet provides health service organisations with information about the Electronic Medication Management Self-Assessment Tool (EMMSAT). It describes how it can be used to support quality improvement activities to optimise implementation of electronic medication management (EMM).

This issue includes items on funding, reporting, climate change, engagement, cognitive impairment, social connection, sepsis, and more. Along with the latest from BMJ Quality & Safety.